Closed
Molecular Screening for HBV, HCV and HIV nucleic acids in cadaveric tissue donations.
Descriptions
Please note this is not the start of a procurement process. A separate contract notice will be published to cover this requirement. Prior to commencing a formal procurement process and to help inform our strategy/ requirements, NHSBT is seeking to engage with suppliers of commercially available compact and fully automated molecular screening platform with blood borne virus assays. NHSBT would like to consult the market to improve our knowledge of all current platforms available in the market place, identify further opportunities and, potential issues, and gauge market interest in the proposed service. The equipment will be with minimal user operation and the technology will meet the current and future needs of the service, in a cost effective manner.
Timeline
Pretender :
Not Identified
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
CPV Codes
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors